| Report ID |
108380 |
| Drug Identification Number |
00637661 |
| Brand name |
BETAGAN 0.5% OPHTHALMIC SOL |
| Common or Proper name |
Betagan 0.5% |
| Company Name |
ALLERGAN INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
LEVOBUNOLOL HYDROCHLORIDE |
| Strength(s) |
5MG |
| Dosage form(s) |
LIQUID |
| Route of administration |
OPHTHALMIC |
| Packaging size |
10ml |
| ATC code |
S01ED |
| ATC description |
ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for discontinuation |
Business reasons |
| Anticipated discontinuation date |
2020-02-01 |
| Actual discontinuation date |
2020-02-01 |
| Remaining supply date |
2020-02-01 |
| Discontinuation status |
Discontinued |
| Discontinuation decision reversal |
No |
| Information on remaining supply |
|
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
Company contact information;
Telephone number: 800-668-6424
Email address: MR-GENERAL_INQUIRY@allergan.com
Website address: allergan.ca
Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
